Literature DB >> 22521737

Genistein regulates the IL-1 beta induced activation of MAPKs in human periodontal ligament cells through G protein-coupled receptor 30.

Li-Jun Luo1, Feng Liu, Zhi-Kai Lin, Yu-Feng Xie, Jia-Li Xu, Qing-Chun Tong, Rong Shu.   

Abstract

Periodontal ligament (PDL) cells are fibroblasts that play key roles in tissue integrity, periodontal inflammation and tissue regeneration in the periodontium. The periodontal tissue destruction in periodontitis is mediated by host tissue-produced inflammatory cytokines, including interleukin-1β (IL-1β). Here, we report the expression of G protein-coupled receptor 30 (GPR30, also known as G protein-coupled estrogen receptor 1 GPER) in human PDL cells and its regulation by IL-1β. IL-1β-induced GPR30 expression in human PDL cells leads to the activation of multiple signaling pathways, including MAPK, NF-κB and PI3K. In contrast, genistein, an estrogen receptor ligand, postpones the activation of MAPKs induced by IL-1β. Moreover, the inhibition of GPR30 by G15, a GPR30-specific antagonist, eliminates this delay. Thus, genistein plays a role in the regulation of MAPK activation via GPR30, and GPR30 represents a novel target regulated by steroid hormones in PDL cells.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22521737     DOI: 10.1016/j.abb.2012.04.007

Source DB:  PubMed          Journal:  Arch Biochem Biophys        ISSN: 0003-9861            Impact factor:   4.013


  19 in total

1.  Antagonism of human formyl peptide receptor 1 (FPR1) by chromones and related isoflavones.

Authors:  Igor A Schepetkin; Liliya N Kirpotina; Andrei I Khlebnikov; Ni Cheng; Richard D Ye; Mark T Quinn
Journal:  Biochem Pharmacol       Date:  2014-10-17       Impact factor: 5.858

Review 2.  Microglia mediated neuroinflammation - signaling regulation and therapeutic considerations with special reference to some natural compounds.

Authors:  Yue-Yi Yao; Eng-Ang Ling; Di Lu
Journal:  Histol Histopathol       Date:  2020-07-14       Impact factor: 2.303

3.  Activation of G protein coupled estrogen receptor (GPER) promotes the migration of renal cell carcinoma via the PI3K/AKT/MMP-9 signals.

Authors:  Bao-Zhang Guan; Rui-Ling Yan; Jian-Wei Huang; Fo-Lan Li; Ying-Xue Zhong; Yu Chen; Fan-Na Liu; Bo Hu; Si-Bo Huang; Liang-Hong Yin
Journal:  Cell Adh Migr       Date:  2018-01-29       Impact factor: 3.405

Review 4.  GPER-novel membrane oestrogen receptor.

Authors:  Margaret A Zimmerman; Rebecca A Budish; Shreya Kashyap; Sarah H Lindsey
Journal:  Clin Sci (Lond)       Date:  2016-06-01       Impact factor: 6.124

Review 5.  Unsung renal receptors: orphan G-protein-coupled receptors play essential roles in renal development and homeostasis.

Authors:  P Rajkumar; J L Pluznick
Journal:  Acta Physiol (Oxf)       Date:  2016-10-23       Impact factor: 6.311

Review 6.  Genistein: the potential for efficacy in rheumatoid arthritis.

Authors:  Jinchao Li; Dong Gang; Xiaowei Yu; Yiping Hu; Ye Yue; Wenxiang Cheng; Xiaohua Pan; Peng Zhang
Journal:  Clin Rheumatol       Date:  2013-01-10       Impact factor: 2.980

7.  Activation of GPER suppresses epithelial mesenchymal transition of triple negative breast cancer cells via NF-κB signals.

Authors:  Zhuo-Jia Chen; Wei Wei; Guan-Min Jiang; Hao Liu; Wei-Dong Wei; Xiangling Yang; Ying-Min Wu; Huanliang Liu; Chris K C Wong; Jun Du; Hong-Sheng Wang
Journal:  Mol Oncol       Date:  2016-01-18       Impact factor: 6.603

Review 8.  Flavonoids: structure-function and mechanisms of action and opportunities for drug development.

Authors:  Stephen Safe; Arul Jayaraman; Robert S Chapkin; Marcell Howard; Kumaravel Mohankumar; Rupesh Shrestha
Journal:  Toxicol Res       Date:  2021-01-20

9.  Colloidal aggregation causes inhibition of G protein-coupled receptors.

Authors:  Maria F Sassano; Allison K Doak; Bryan L Roth; Brian K Shoichet
Journal:  J Med Chem       Date:  2013-03-12       Impact factor: 7.446

10.  The activation of G protein-coupled receptor 30 (GPR30) inhibits proliferation of estrogen receptor-negative breast cancer cells in vitro and in vivo.

Authors:  W Wei; Z-J Chen; K-S Zhang; X-L Yang; Y-M Wu; X-H Chen; H-B Huang; H-L Liu; S-H Cai; J Du; H-S Wang
Journal:  Cell Death Dis       Date:  2014-10-02       Impact factor: 8.469

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.